SHANGHAI MICURX PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.35 CNY | +3.82% |
|
-3.97% | -33.38% |
| Sales 2024 * | 161M 22.16M 30.3M | Sales 2025 * | 256M 35.16M 48.09M | Capitalization | 2.85B 392M 536M |
|---|---|---|---|---|---|
| Net income 2024 * | -423M -58.21M -79.61M | Net income 2025 * | -411M -56.56M -77.36M | EV / Sales 2024 * | 17.7 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 11.2 x |
| P/E ratio 2024 * |
-6.74
x | P/E ratio 2025 * |
-6.96
x | Employees | 205 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.36% |
More Fundamentals
* Assessed data
| 1 day | +3.82% | ||
| 1 week | -3.97% | ||
| Current month | -3.33% | ||
| 1 month | -0.68% | ||
| 3 months | -21.62% | ||
| 6 months | -32.24% | ||
| Current year | -33.38% |
1 week
4.12
4.57
1 month
3.914.57
Current year
3.236.77
1 year
3.238.86
3 years
3.2314.20
5 years
3.2314.20
10 years
3.2314.20
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-28 | 4.35 | +3.82% | 5,834,465 |
| 24-06-27 | 4.19 | -4.56% | 3,594,247 |
| 24-06-26 | 4.39 | +2.09% | 2,794,620 |
| 24-06-25 | 4.3 | -1.15% | 3,091,368 |
| 24-06-24 | 4.35 | -3.97% | 6,093,514 |
End-of-day quote Shanghai S.E., June 27, 2024
More quotes
Shanghai MicuRx Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development (R&D) and commercialization of innovative drugs. The Company's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The Company also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The Company operates its businesses primarily in the domestic market.
Sector
Pharmaceuticals
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.35
CNY
Average target price
6.875
CNY
Spread / Average Target
+58.05%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.38% | 392M | |
| +55.32% | 815B | |
| -6.75% | 352B | |
| +13.56% | 314B | |
| +10.68% | 303B | |
| +16.57% | 242B | |
| +2.04% | 224B | |
| +13.31% | 218B | |
| +8.48% | 168B | |
| -2.81% | 159B |
- Stock Market
- Equities
- 688373 Stock
